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Editorial
Lipids in functional foods, nutraceuticals
and supplements
In recent decades, there has been a growing interest in the concept of ‘functional foods’ within
the food industry and from the consumers, but although many definitions exist for functional
foods, an official, internationally accepted definition is still missing. The concept of functional
foods derives from the awareness that specific components of the diet have beneficial effects on
the health and well-being and have a potential role in reducing risks of disease.
Some foods which are commonly consumed in the daily diet, such as fruits, vegetables,
grains, fish and dairy products, are widely studied for their many natural components that
contribute benefits beyond those of basic nutrition. An important group of compounds within
unsaturated fatty acids are the long-chain (C16–C20), PUFA (LC-PUFAs). Humans can
synthesize certain fatty acids, but are unable to desaturate long-chain fatty acids at either C3 or
C6 from the methyl end, making them essential. Examples of foods rich in v-3 PUFA are
anchovies, sardines, mackerels and other fatty fish.
Plant sterols (or phytosterols), the formulations and effects of which have been recently
reviewed in EJLST [1], are naturally contained in vegetables oils, cereals, tree nuts and
legumes, represent another important group of fat components widely studied for their
capacity of lowering serum concentrations of cholesterol. This effect occurs because plant
sterols, being structurally similar to cholesterol, reduce its absorption from the gut.
Functional foods can be traditional foods or foods in which one or several components
have been modified, removed or reduced (e.g. a yoghurt with reduced fat), added (e.g. spread
with added phytosterols), replaced or enhanced (e.g. a juice with enhanced antioxidant
content) to improve the benefits. This can also be achieved through innovative technological
approaches developed by the food industry.
Results from epidemiologic and clinical studies have indicated that the consumption ofv-3
PUFAs, namely eicosapentaenoic acid (EPA) and docosaesaenoic acid (DHA), and of
phytosterols (mainly b-sitosterol, campesterol and stigmasterol) have positive effects in
decreasing risk factors of cardiovascular diseases.
Several groups studied the incorporation of phytosterols in various foods rich in fats, such
as margarine, salad dressing, cream-cheese, milk and yogurt [2–4]. In double-blind placebo-
controlled randomized studies, it has been demonstrated that the consumption of phytosterol-
enriched fermented milk was associated with a significant decrease in plasma concentrations of
low-density-lipoprotein cholesterol as compared with the consumption of placebo [5–7].
The lipid-lowering effect of milk enriched with v-3 PUFAs has also been investigated in
various clinical trials [9]. Milk fat is considered an efficient vehicle to favour the adsorption of
fat and lipid-soluble compounds (v-3 PUFAs, oleic acid, vitamin E, etc.), because of
its dispersion in very small micelles [7, 8]. The formulations, sources and effects of v-3
PUFAs on human and animal health have been widely considered in studies published in
EJLST [10–12].
This special issue on ‘Lipids in Functional Foods’ focuses on: (i) new sources for lipids
with health beneficial properties to improve the value of low quality foods, and (ii) innovative
technological approaches to enhance their analysis, extraction procedures or to enrich the
nutritional profile of traditional foods.
Caramia and colleagues [p. 375–388] reviewed current studies on extra virgin olive oil as a
traditional ‘fat’ functional food, providing components of great interest for the reduction of
risk factors for several pathological conditions. The antioxidant activities of the constituents of
vegetable oils have been investigated by Nakbi et al. [p. 469–478] in adult rats. Murine models
have been exploited by Xiao and colleagues [p. 461–468] to study the beneficial effects of cold-
pressed flaxseed oils, enriched with vitamin E, on lipid profile and antioxidant status.
Triacylglycerols, the main components of edible oils, differ in the total length of acyl chains
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and the degree of unsaturation. A review by Kalo and Kemppinen [p. 399–411] deals with
analytical methods to separate the regioisomers, whose determination is important to under-
stand the digestion, absorption and metabolism of TAGs, as well as their physical and
technological properties.
The papers by Chemat and colleagues [p. 453–460] and Monfalouti and colleagues
[p. 446–452] investigated potential innovative sources for healthy ingredients using sea
buckthorn by-products to obtain carotenoids and argan fruits pulp as a novel source of
polyphenols.
The organoleptic characteristics and nutritive profile of a soup enriched with micro-
encapsulated linseed oil, which is a natural source of a-linolenic acid, have been investigated
by Rubilar et al. [p. 423–433]. The microencapsulation is a new technological approach used
by the food industry to prevent lipid peroxidation. Another way to prevent oxidation is by
adding antioxidants – the potential of lipophilized phenolic compounds has been evaluated by
Sørensen and colleagues [p. 434–445]. The health benefits of a fish meal diet enriched with v-
3 PUFAs have been studied by Ontsouka et al. [p. 412–422] in alleviating intestinal inflam-
matory activity in dogs affected by chronic enteropathies.
Gorissen et al. [p. 486–491] investigated the capacity of some bifidobacterium and
lactobacillus strains to produce CLA and conjugated linolenic acid (CLNA) with the aim
to enrich fermented milk and meat with these compounds; the effects of CLAs on human
carcinoma cell lines were also studied in vitro by Zhong and colleagues [p. 479–485].
This special issue is the fruit of a joint effort by ourselves and the Journal, represented by
Uwe Bornscheuer, Lucie Kalvodova and all the Associate Editors.
The topics covered in this issue should be valuable for those doing basic research as well as
the food industry. We hope that you will find the articles on how lipids can contribute to the
human health and well-being interesting.
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